Zoledronic Acid as a Therapeutic Option for Hypercalcemia in Subcutaneous Fat Necrosis: Series of Four Infants

View at publisher Summarise with VIRAT
Authors: Kalyani Kotthurthi, Anju Bala, Sayan Banerjee, Arun George, Mohit Kumar, Rakesh Kumar, Devi Dayal, Jaivinder Yadav
Cited by: 0
References: 13

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Subcutaneous fat necrosis (SFN) of the newborn is a self-limiting condition, yet the associated hypercalcemia may result in life-threatening complications. We report a series of four term infants who developed symptomatic hypercalcemia secondary to SFN. Clinical features included firm subcutaneous nodules and elevated serum calcium levels, with suppressed parathyroid hormone (PTH) levels. Management comprises early recognition of SFN-associated hypercalcemia and prompt treatment. We hereby report the use of a single dose of zoledronic acid as an effective therapy for the resolution of hypercalcemia.

Fields of Study & Subjects

Parathyroid Disorders and Treatments Bone health and treatments Neonatal skin health care

Publication details

Journal / source
Journal of Neonatology
Publication date
26 March 2026
Language
EN